1. Home
  2. SURG vs ATNM Comparison

SURG vs ATNM Comparison

Compare SURG & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

N/A

Current Price

$0.79

Market Cap

18.3M

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.19

Market Cap

36.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SURG
ATNM
Founded
2006
2000
Country
United States
United States
Employees
20
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
36.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SURG
ATNM
Price
$0.79
$1.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.75
$4.00
AVG Volume (30 Days)
166.4K
115.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.60
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
$3.78
N/A
Revenue Next Year
$113.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$1.02
52 Week High
$3.47
$1.95

Technical Indicators

Market Signals
Indicator
SURG
ATNM
Relative Strength Index (RSI) 33.42 52.28
Support Level $0.75 $1.02
Resistance Level $0.95 $1.71
Average True Range (ATR) 0.06 0.07
MACD 0.03 0.02
Stochastic Oscillator 20.96 77.78

Price Performance

Historical Comparison
SURG
ATNM

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: